- >=99.0 HPLCHPLC / MSIn stock
Research compound
GLP-2(T)
GLP-2(T) (Tirzepatide) is a protease-stabilized 39-amino-acid dual incretin receptor co-agonist carrying Aib substitutions at positions 2 and 13 that block DPP-IV cleavage, plus a C20 fatty diacid moiety on Lys20 that extends biochemical half-life through albumin binding. Receptor engagement is documented at both the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), where concurrent Gs-coupled cAMP elevation is studied in pancreatic beta-cell and adipocyte culture systems. Tirzepatide serves as a pharmacological benchmark for combinatorial GIPR/GLP-1R signaling assays. Supplied lyophilized for in vitro research use only.
Specification
- CAS
- 2023788-19-2
- Molecular weight
- 4813.53 g/mol
- Formula
- C225H348N48O68
- Purity
- >=99.0 HPLC
- Storage
- -20 °C, lyophilized
Size
Research notes
What is GLP-2(T)?
GLP-2(T) is a synthetic research compound studied in laboratory settings. It has molecular formula C225H348N48O68, a molecular weight of 4813.53 g/mol, CAS 2023788-19-2. It is intended for in vitro research use only and is not for human or animal use.
What purity is Valitec Peptides's GLP-2(T)?
Valitec Peptides supplies GLP-2(T) at >=99.0% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is GLP-2(T) supplied?
GLP-2(T) is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic use.